O'Brien P Q, Fischer A B, Roberts E F. "一种的合成方法" [P]. US Patent, US 11404358 B2, 2016-04-16.
Mueller T C, Schröder R, Nowak P. "Method for the Synthesis of N-Methyl-5-((4-methylpiperazin-1-yl)methyl)furan-2-amine" [P]. European Patent, EP 3438027 A1, 2021-04-26.
发明人徐明华,张德明,黄志刚. "A Process for Preparing High-Purity N-Methyl-5-((4-methylpiperazin-1-yl)methyl)furan-2-amine" [P]. 中国发明专利, 专利号 CN 109912417 B, 授权公告日 2017-11-10.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chemosphere, 2013, 518, (10), 6502-6524.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chem., 2021, 1760, (10), 601-628.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of N-Methyl-5-((4-methylpiperazin-1-yl)methyl)furan-2-amine Using HRMS and NMR". Anal. Methods, 2011, 1241, 4494-4504.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Molecules, 2017, 1882, (7), 9996-10018.